BUHLMANN LABORATORIES AG
- Shared products
- ADALIMUMAB (ADL), ANTI-ADALIMUMAB ANTIBODIES (ADL), ANTI-INFLIXIMAB (IFX) ANTIBODIES, CALPROTECTIN, INFLIXIMAB (IFX)
- Shared products
- ADALIMUMAB (ADL), ANTI-ADALIMUMAB ANTIBODIES (ADL), CALPROTECTIN, FLASK OR MATERIAL FOR COLLECTION, STORAGE OR TRANSPORT OF BIOLOGICAL SAMPLES
- Shared products
- FLASK OR MATERIAL FOR COLLECTION, STORAGE OR TRANSPORT OF BIOLOGICAL SAMPLES, INFLIXIMAB (IFX), PANCREATIC ELASTASE 1
- Shared products
- ANTI-GANGLIOSIDE ANTIBODIES, ANTI-MYELIN ASSOCIATED GLYCOPROTEIN (MAG) ANTIBODY, CALPROTECTIN
- Shared products
- CALPROTECTIN, FLASK OR MATERIAL FOR COLLECTION, STORAGE OR TRANSPORT OF BIOLOGICAL SAMPLES, PANCREATIC ELASTASE 1
Explore comprehensive manufacturer profile for BUHLMANN LABORATORIES AG based in Switzerland through Pure Global AI's free Brazil medical device database. This manufacturer has 16 products registered with ANVISA across 10 unique technical categories. Their regulatory history spans from Dec 01, 2014 to Jul 08, 2024.
This page provides detailed insights including 5 recent product registrations including ANTI-GANGLIOSIDE ANTIBODIES, 5 most popular products with CALPROTECTIN having 4 registrations, 2 registration holders including VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA, and 5 key competitors with BODITECH MED INC. sharing 5 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.